Mabron 200mg modified-release tablets (Morningside)
BNF presentation 040702040BHACAE within chapter Central Nervous System. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Chapter
Presentation code
040702040BHACAE
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
12
NHS spend (£)
£170.18
Recent activity
July 2021
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| July 2021 | 4 |
| December 2020 | 2 |
| November 2020 | 6 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 7 | No data available |
|
The Mullion & Constantine Group Practice
ODS L82056
|
4 | 11N - CORNWALL & THE ISLES OF SCILLY ICB |
|
Riverside Medical Centre
ODS P81185
|
1 | 01E - LANCASHIRE AND SOUTH CUMBRIA ICB |